146 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
other Subsidiary.
(i) Reserved.
(j) Independent Accountants. The accountants who certified the audited financial statements of the Company included … or incorporated by reference in the Registration Statement and the Prospectus are an independent registered public accounting firm as required
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
constitution and only exercise his or her powers for the purposes for which they are conferred;
∎ to exercise independent judgment;
∎ to exercise … , 2023 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given
S-3
EX-23.3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
report and accounts for the year ended December 31, 2023, together with the directors’ report and independent auditor’s report thereon, be received … to instruct Citibank, N.A. how to vote your ADSs.
Who counts the votes?
Link Group has been engaged as our independent agent to tabulate shareholder votes
10-K
2023 FY
EX-23.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration
10-K
EX-10.30
xdsg49x3 35nu9cv8dke
27 Mar 24
Annual report
5:20pm
10-K
gkk1uzycjo
27 Mar 24
Annual report
5:20pm
10-K
EX-19.1
6mpzc7h
27 Mar 24
Annual report
5:20pm
S-8
EX-23.2
lsz1afiy8oq853gm4s8w
23 Jan 24
Registration of securities for employees
4:16pm
S-8
tvgg gf1624
23 Jan 24
Registration of securities for employees
4:16pm
6-K
EX-99.1
juqr fdqh
16 Nov 23
Current report (foreign)
7:01am
6-K
EX-99.1
rbd7m48h8rr7myh
23 Oct 23
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
4:08pm
6-K
pt3 0uh3nzo3
20 Sep 23
Current report (foreign)
4:03pm
6-K
EX-16.1
e8677os74d4dmgd
20 Sep 23
Current report (foreign)
4:03pm
6-K
EX-99.3
al8cy1oyxokdu
7 Sep 23
Current report (foreign)
7:37am
6-K
g59y8
22 May 23
Current report (foreign)
4:15pm
6-K
0j1s7l
10 Nov 22
Current report (foreign)
4:06pm
6-K
EX-99.2
ljcutx3dklel bd0
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-99.2
tp4bg7s
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
EX-99.1
i9c6 r9vb7q7j1lfpmz
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am